Moreover, high mutation rates inFVIII,VWF, andADAMTS13were also found in patients with diffuse large B cell lymphoma (22.9%), lung small cell carcinoma (20.7%), and colon adenocarcinoma (19.4%). This evidence concerns the gene VWF and small cell lung carcinoma.